Release Date: 30/12/21 18:33 Summary: Estimated Distribution Announcement Price Sensitive: Yes Download Document 215.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%